AAAAAA
Results:
1-12
|
Results: 12
Authors:
Lauer, MA
Houghtaling, PL
Peterson, JG
Granger, CB
Bhatt, DL
Sapp, SK
Simoons, ML
Harrington, RA
Topol, EJ
Lincoff, AM
Citation: Ma. Lauer et al., Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acutecoronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 104(23), 2001, pp. 2772-2777
Authors:
Gum, PA
Kottke-Marchant, K
Poggio, EC
Gurm, H
Welsh, PA
Brooks, L
Sapp, SK
Topol, EJ
Citation: Pa. Gum et al., Profile and prevalence of aspirin resistance in patients with cardiovascular disease, AM J CARD, 88(3), 2001, pp. 230-235
Authors:
Peterson, JG
Topol, EJ
Roe, MT
Sapp, SK
Lincoff, AM
Deckers, JW
Blackstone, EH
Harrington, RA
Califf, RM
Lauer, MS
Citation: Jg. Peterson et al., Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes, AM J CARD, 87(5), 2001, pp. 532-536
Authors:
Roe, MT
Sapp, SK
Lincoff, AM
Citation: Mt. Roe et al., Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes, CLEV CLIN J, 67(2), 2000, pp. 131-140
Authors:
Lincoff, AM
LeNarz, LA
Despotis, GJ
Smith, PK
Booth, JE
Raymond, RE
Sapp, SK
Cabot, CF
Tcheng, JE
Califf, RM
Effron, MB
Topol, EJ
Citation: Am. Lincoff et al., Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials, ANN THORAC, 70(2), 2000, pp. 516-526
Authors:
Yamamuro, M
Lytle, BW
Sapp, SK
Cosgrove, DM
Loop, FD
McCarthy, PM
Citation: M. Yamamuro et al., Risk factors and outcomes after coronary reoperation in 739 elderly patients, ANN THORAC, 69(2), 2000, pp. 464-474
Authors:
Peterson, JG
Topol, EJ
Sapp, SK
Young, JB
Lincoff, AM
Lauer, MS
Citation: Jg. Peterson et al., Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease, AM J MED, 109(5), 2000, pp. 371-377
Authors:
Brener, SJ
Ellis, SG
Sapp, SK
Betriu, A
Granger, CB
Burchenal, JEB
Moliterno, DJ
Califf, RM
Topol, EJ
Citation: Sj. Brener et al., Predictors of death and reinfarction at 30 days after primary angioplasty:The GUSTO IIb and RAPPORT trials, AM HEART J, 139(3), 2000, pp. 476-481
Authors:
Lincoff, AM
Califf, RM
Moliterno, DJ
Ellis, SG
Ducas, J
Kramer, JH
Kleiman, NS
Cohen, EA
Booth, JE
Sapp, SK
Cabot, CF
Topol, EJ
Citation: Am. Lincoff et al., Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors, N ENG J MED, 341(5), 1999, pp. 319-327
Authors:
Marso, SP
Lincoff, AM
Ellis, SG
Bhatt, DL
Tanguay, JF
Kleiman, NS
Hammoud, T
Booth, JE
Sapp, SK
Topol, EJ
Citation: Sp. Marso et al., Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus - Results of the EPISTENT (Evaluation of Platelet IIb/IIIa inhibitor for Stenting Trial) diabetic substudy, CIRCULATION, 100(25), 1999, pp. 2477-2484
Authors:
Scirica, BM
Moliterno, DJ
Every, NR
Anderson, FV
Aguirre, FV
Granger, CB
Lambrew, CT
Rabbani, LE
Arnold, A
Sapp, SK
Booth, JE
Ferguson, JJ
Cannon, CP
Citation: Bm. Scirica et al., Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry), AM J CARD, 84(10), 1999, pp. 1145-1150
Authors:
Scirica, BM
Moliterno, DJ
Every, NR
Anderson, HV
Aguirre, FV
Granger, CB
Lambrew, CT
Rabbani, LE
Sapp, SK
Booth, JE
Ferguson, JJ
Cannon, CP
Citation: Bm. Scirica et al., Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry, AM HEART J, 138(6), 1999, pp. 1065-1072
Risultati:
1-12
|